Filana Therapeutics (FLNA) Times Interest Earned (2010 - 2026)
Filana Therapeutics (FLNA) posted quarterly Times Interest Earned of -$57.27 for Q2 2026, up 80.32% year-over-year from -$31.76 in Q2 2025, and down 5.65% quarter-over-quarter from -$54.21 in Q1 2026.
Filana Therapeutics (FLNA) Times Interest Earned (2010 - 2026) Analysis & Trends
Filana Therapeutics' Times Interest Earned history runs 17 years deep, the most recent figure standing at -$57.27 for Q2 2026.
- In Q2 2026, Times Interest Earned rose 80.32% year-over-year to -$57.27; the TTM figure through Jun 2026 stood at -$62.8 (up 63.89% YoY), while the FY2025 annual figure was -$0.85, up 41.73% from the prior year.
- Times Interest Earned for Q2 2026 stood at -$57.27, down from -$54.21 in the prior quarter.
- The five-year high for Times Interest Earned was -$48.69 in Q4 2022, with the low at -$290.97 in Q2 2025.
- The 5-year median for Times Interest Earned is -$77.61 (2023), against an average of -$105.64.
- Peak annual rise in Times Interest Earned reached 86.18% in 2022, while the deepest fall reached 406.04% in 2022.
- Filana Therapeutics' Times Interest Earned stood at -$48.69 in 2022, then slumped by 59.74% to -$77.78 in 2023, then sank by 154.44% to -$197.9 in 2024, then surged by 48.12% to -$102.67 in 2025, then soared by 44.21% to -$57.27 in 2026.
- Business Quant data shows FLNA's Times Interest Earned at -$57.27 in Q2 2026, -$54.21 in Q1 2026, and -$102.67 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | -57.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -57.27 |
| Mar 31, 2026 | -54.21 |
| Dec 31, 2025 | -102.67 |
| Sep 30, 2025 | -51.57 |
| Jun 30, 2025 | -290.97 |
| Mar 31, 2025 | -113.30 |
| Dec 31, 2024 | -197.90 |
| Sep 30, 2024 | -135.50 |
| Jun 30, 2024 | -285.59 |
| Mar 31, 2024 | -82.03 |
| Dec 31, 2023 | -77.78 |
| Sep 30, 2023 | -77.44 |
| Jun 30, 2023 | -80.83 |
| Mar 31, 2023 | -72.24 |
| Dec 31, 2022 | -48.69 |
| Sep 30, 2022 | -52.06 |
| Jun 30, 2022 | -64.04 |
| Mar 31, 2022 | -57.49 |
| Dec 31, 2021 | -352.29 |
| Sep 30, 2021 | -237.88 |